-
2
-
-
0021360688
-
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria
-
Chin NX, Neu HC. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1984; 25: 319-326. (Pubitemid 14166483)
-
(1984)
Antimicrobial Agents and Chemotherapy
, vol.25
, Issue.3
, pp. 319-326
-
-
Chin, N.X.1
Neu, H.C.2
-
3
-
-
0021213694
-
Mutational resistance to 4-quinolone antibacterial agents
-
Smith JT. Mutational resistance to 4-quinolone antibacterial agents. European Journal of Clinical Microbiology 1984; 3: 347-350. (Pubitemid 14034599)
-
(1984)
European Journal of Clinical Microbiology
, vol.3
, Issue.4
, pp. 347-350
-
-
Smith, J.T.1
-
4
-
-
0021995468
-
Comparative evaluation of recently developed quinolone compounds - with a note on the frequency of resistant mutants
-
Cullmann W, et al. Comparative evaluation of recently developed quinolone compounds - with a note on the frequency of resistant mutants. Chemotherapy 1985; 31: 19-28. (Pubitemid 15184153)
-
(1985)
Chemotherapy
, vol.31
, Issue.1
, pp. 19-28
-
-
Cullmann, W.1
Stieglitz, M.2
Baars, B.3
Opferkuch, W.4
-
6
-
-
0029145907
-
Epidemiology of quinolone resistance : Europe and North and South America
-
Goldstein FW, Acar JF. Epidemiology of quinolone resistance : Europe and North and South America. Drugs 1995; 49: 36-42.
-
(1995)
Drugs
, vol.49
, pp. 36-42
-
-
Goldstein, F.W.1
Acar, J.F.2
-
7
-
-
54949148412
-
NHSN annual update: Antimicrobialresistant pathogens associated with healthcareassociated infections: Reported to the national healthcare safety network at the centers for disease control and prevention, 2006- 2007
-
Hidron AI, et al. NHSN annual update: antimicrobialresistant pathogens associated with healthcareassociated infections : annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infection Control and Hospital Epidemiology 2008; 29: 996-1011.
-
(2008)
Infection Control and Hospital Epidemiology
, vol.29
, pp. 996-1011
-
-
Hidron, A.I.1
-
8
-
-
0035494991
-
A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study)
-
DOI 10.1046/j.1198-743X.2001.00324.x
-
Bouza E, et al. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clinical Microbiology and Infection 2001; 7: 532-542. (Pubitemid 34960343)
-
(2001)
Clinical Microbiology and Infection
, vol.7
, Issue.10
, pp. 532-542
-
-
Bouza, E.1
San Juan, R.2
Munoz, P.3
Voss, A.4
Kluytmans, J.5
-
9
-
-
46049106923
-
Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis
-
Naber KG, et al. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis. International Journal of Antimicrobial Agents 2008; 32: 145-153.
-
(2008)
International Journal of Antimicrobial Agents
, vol.32
, pp. 145-153
-
-
Naber, K.G.1
-
10
-
-
0031006762
-
Assessment of the synergistic interactions of levofloxacin and ampicillin against Enterococcus faecium by the checkerboard agar dilution and time-kill methods
-
DOI 10.1016/S0732-8893(96)00222-2, PII S0732889396002222
-
Smith CE, et al. Assessment of the synergistic interactions of levofloxacin and ampicillin against Enterococcus faecium by the checkerboard agar dilution and time-kill methods. Diagnostic Microbiology and Infectious Diseases 1997; 27: 85-92. (Pubitemid 27224324)
-
(1997)
Diagnostic Microbiology and Infectious Disease
, vol.27
, Issue.3
, pp. 85-92
-
-
Smith, C.E.1
Foleno, B.E.2
Barrett, J.F.3
Frosco, M.B.4
-
11
-
-
0027199455
-
Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin
-
Landman D, Mobarakai NK, Quale JM. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrobial Agents and Chemotherapy 1993; 37: 1904-1908. (Pubitemid 23265550)
-
(1993)
Antimicrobial Agents and Chemotherapy
, vol.37
, Issue.9
, pp. 1904-1908
-
-
Landman, D.1
Mobarakai, N.K.2
Quale, J.M.3
-
12
-
-
0027371911
-
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium
-
Whitman MS, et al. Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin- resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 1993; 37: 2069-2073. (Pubitemid 23298191)
-
(1993)
Antimicrobial Agents and Chemotherapy
, vol.37
, Issue.10
, pp. 2069-2073
-
-
Whitman, M.S.1
Pitsakis, P.G.2
Zausner, A.3
Livornese, L.L.4
Osborne, A.J.5
Johnson, C.C.6
Levison, M.E.7
-
13
-
-
0023821657
-
CDC definitions for nosocomial infections, 1988
-
Garner JS, et al. CDC definitions for nosocomial infections, 1988. American Journal of Infection Control 1988; 16: 128-140.
-
(1988)
American Journal of Infection Control
, vol.16
, pp. 128-140
-
-
Garner, J.S.1
-
14
-
-
84969254848
-
Performance standards for antimicrobial susceptibility testing
-
Clinical and Laboratory Standards Institute,Wayne, PA: CLSI
-
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing ; eighteenth informational supplement: M100-S18. Wayne, PA: CLSI, 2008.
-
(2008)
Eighteenth Informational Supplement: M100-S18
-
-
-
15
-
-
33748749522
-
Investigating the association between antibiotic use and antibiotic resistance: Impact of different methods of categorising prior antibiotic use
-
DOI 10.1016/j.ijantimicag.2006.04.014, PII S092485790600224X
-
MacAdam H, et al. Investigating the association between antibiotic use and antibiotic resistance : impact of different methods of categorising prior antibiotic use. International Journal of Antimicrobial Agents 2006; 28: 325-332. (Pubitemid 44402991)
-
(2006)
International Journal of Antimicrobial Agents
, vol.28
, Issue.4
, pp. 325-332
-
-
MacAdam, H.1
Zaoutis, T.E.2
Gasink, L.B.3
Bilker, W.B.4
Lautenbach, E.5
-
16
-
-
36549033219
-
The categorization of prior antibiotic use: Impact on the identification of risk factors for drug resistance in case control studies
-
DOI 10.1016/j.ajic.2007.01.011, PII S0196655307004609
-
Gasink LB, et al. The categorization of prior antibiotic use: impact on the identification of risk factors for drug resistance in case control studies. American Journal of Infection Control 2007; 35: 638-642. (Pubitemid 350184159)
-
(2007)
American Journal of Infection Control
, vol.35
, Issue.10
, pp. 638-642
-
-
Gasink, L.B.1
Zaoutis, T.E.2
Bilker, W.B.3
Lautenbach, E.4
-
17
-
-
0035310496
-
Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review
-
DOI 10.1086/319600
-
Harris AD, et al. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance : a systematic review. Clinical Infectious Diseases 2001; 32: 1055-1061. (Pubitemid 32299641)
-
(2001)
Clinical Infectious Diseases
, vol.32
, Issue.7
, pp. 1055-1061
-
-
Harris, A.D.1
Karchmer, T.B.2
Carmeli, Y.3
Samore, M.H.4
-
18
-
-
0037175524
-
Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections
-
DOI 10.1001/archinte.162.21.2469
-
Lautenbach E, et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Archives of Internal Medicine 2002; 162: 2469-2477. (Pubitemid 35340464)
-
(2002)
Archives of Internal Medicine
, vol.162
, Issue.21
, pp. 2469-2477
-
-
Lautenbach, E.1
Fishman, N.O.2
Bilker, W.B.3
Castiglioni, A.4
Metlay, J.P.5
Edelstein, P.H.6
Strom, B.L.7
-
19
-
-
27744518336
-
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey
-
DOI 10.1093/jac/dki344
-
Arslan H, et al. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community- acquired urinary tract infections in Turkey. Journal of Antimicrobial Agents and Chemotherapy 2005; 56: 914-918. (Pubitemid 41631917)
-
(2005)
Journal of Antimicrobial Chemotherapy
, vol.56
, Issue.5
, pp. 914-918
-
-
Arslan, H.1
Azap, O.K.2
Ergonul, O.3
Timurkaynak, F.4
Aydin, K.5
Bakir, M.6
Balaban, N.7
Baykam, N.8
Cagir, U.9
Caylan, R.10
Elaldi, N.11
Erdogan, H.12
Fincanci, M.13
Hasimoglu, R.14
Izat, A.15
Karabay, O.16
Karaman, S.17
Mutlu, S.18
Ozakim, C.19
Ozdemir, D.20
Parlak, E.21
Parkak, M.22
Sencan, I.23
Serefhanoglu, K.24
Sinirtas, M.25
Sirmatel, F.26
Tasbakan, M.27
Turan, H.28
Turunc, T.29
Ulusoy, S.30
Uncu, H.31
Willke-Topcu, A.32
more..
-
20
-
-
3042643373
-
Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection
-
DOI 10.1345/aph.1D622
-
Killgore KM, March KL, Guglielmo BJ. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Annals of Pharmacotherapy 2004; 38: 1148-1152. (Pubitemid 38802150)
-
(2004)
Annals of Pharmacotherapy
, vol.38
, Issue.7-8
, pp. 1148-1152
-
-
Killgore, K.M.1
March, K.L.2
Guglielmo, B.J.3
-
21
-
-
78349312016
-
Risk factors for fluoroquinolone resistance in gram-negative bacilli causing healthcare-acquired urinary tract infections
-
in press
-
Rattanaumpawan P, et al. Risk factors for fluoroquinolone resistance in gram-negative bacilli causing healthcare-acquired urinary tract infections. Journal of Hospital Infection (in press).
-
Journal of Hospital Infection
-
-
Rattanaumpawan, P.1
-
22
-
-
43049170461
-
Bacteremia in previously hospitalized patients : Prolonged effect from previous hospitalization and risk factors for antimicrobial-resistant bacterial infections
-
Chen SY, et al. Bacteremia in previously hospitalized patients : prolonged effect from previous hospitalization and risk factors for antimicrobial-resistant bacterial infections. Annals of Emergency Medicine 2008; 51: 639-646.
-
(2008)
Annals of Emergency Medicine
, vol.51
, pp. 639-646
-
-
Chen, S.Y.1
-
23
-
-
67651113947
-
Risk factors and outcomes associated with isolation of meropenem highlevel- resistant Pseudomonas aeruginosa
-
Eagye KJ, Kuti JL, Nicolau DP. Risk factors and outcomes associated with isolation of meropenem highlevel- resistant Pseudomonas aeruginosa. Infection Control and Hospital Epidemiology 2009; 30: 746-752.
-
(2009)
Infection Control and Hospital Epidemiology
, vol.30
, pp. 746-752
-
-
Eagye, K.J.1
Kuti, J.L.2
Nicolau, D.P.3
-
24
-
-
34250759244
-
Prevention of infective endocarditis : Guidelines from the American Heart Association : A guideline from the American Heart Association rheumatic fever, endocarditis, and kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary
-
Wilson W, et al. Prevention of infective endocarditis : guidelines from the American Heart Association : a guideline from the American Heart Association rheumatic fever, endocarditis, and kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation 2007; 116: 1736-1754.
-
(2007)
Circulation
, vol.116
, pp. 1736-1754
-
-
Wilson, W.1
|